Rapid-acting insulin compositions
US10925931B2 · kind B2 · utility
1Cited by
18References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2018 |
| Grant date | Feb 23, 2021 |
| Priority date | — |
| Expiry date | Jan 19, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.